Showing results (21-30 of 296) with videos related to

Sort By:
Pageof 30
Archives of Internal Medicine|July 11, 2007
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older menRobert Clarke, Jonathan R Emberson, Sarah Parish, et al.
The New England Journal of Medicine|July 12, 2014
Effects of extended-release niacin with laropiprant in high-risk patients, Martin J Landray, Richard Haynes, et al.
Cardiovascular Drugs and Therapy|March 26, 2003
Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trialsRobert Clarke, Jane Armitage
Current Opinion in Lipidology|July 10, 2004
Cardiovascular outcomes among participants with diabetes in the recent large statin trialsJane Armitage, Louise Bowman
Atherosclerosis|January 2, 2016
Management of residual risk after statin therapyChristina Reith, Jane Armitage
Current Opinion in Lipidology|June 27, 2012
LDL cholesterol targets--how low to go?Richard Bulbulia, Jane Armitage
Current Atherosclerosis Reports|January 10, 2013
Does the benefit from statin therapy extend beyond 5 years?Richard Bulbulia, Jane Armitage
Seminars in Vascular Medicine|October 14, 2005
Diabetes and impaired glucose tolerance: a review of the epidemiological and trial evidence for their role in cardiovascular riskLouise Bowman, Jane Armitage
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 12, 2022
Weight loss in a cardiovascular trial population identifies people at future risk of dementiaPieter van der Veere, Imen Hammami, Georgina Buck, et al.
JAMA Network Open|March 2, 2019
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical TrialsAlison Offer, Matthew Arnold, Robert Clarke, et al.
Pageof 30